CVRdatabase
Menu

Sanos A/S

Public limited companyCVR 26997933HerlevActive

Sanos A/S is a public limited company, based in Herlev, active in research and experimental development on natural sciences and engineering, founded in 2003. Net profit rose 768% from 2024 to 2025, ending at DKK 19.4m. Operations are spread over 3 production units in 3 towns. With 58 employees, the company is about 12 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 42.4m+185.6% vs. 2024
Net profitDKK 19.4m+768.3% vs. 2024
EquityDKK 60.9m+46.7% vs. 2024
Employees58latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 186% (2024 → 2025), to DKK 42.4m.
  • Net profit rose 768% (2024 → 2025), to DKK 19.4m.
  • Equity rose 47% (2024 → 2025), to DKK 60.9m.

Employees

  • 5 fewer employees than a year earlier: 58 (08/2026) against 63 (08/2025).

Management and owners, last 24 months

  • New in management: Mark Høgh Gandrup (director, 01/01/2026), Pierre Khaitrine (chair of the board, 29/07/2026) and José Ignacio Pfeifer (board member, 29/07/2026).
  • Stepped down: Karl Sebastian Inger (chair of the board, 29/07/2026), Jakob Brix Christensen (director, 31/12/2025) and Pierre Khaitrine (board member, 28/07/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60m202020212022202320242025
EquityNet profit
Financial figures for Sanos A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit5,8474,91514,44221,87514,83542,362+185.6%
Operating profit (EBIT)3,6941,7408,30713,1632,73425,426+830.1%
Profit before tax3,6681,6918,27413,2452,82824,982+783.2%
Net profit12,0441,3245,80110,3312,23319,392+768.3%
Total assets38,16041,36439,90047,64748,99076,113+55.4%
Equity21,83023,15428,95639,28741,52060,913+46.7%
Liabilities16,33018,21010,9448,3607,47015,200+103.5%
Cash and cash equivalents1,0081,8761,9871,9613600−100%
Average number of employees–3639475054+8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Sanos A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202503/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202407/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202313/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202226/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202117/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202007/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304050607009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 42.4mNo. 38 of 421
Better than 91% of the companies in the industry
EquityDKK 60.9mNo. 59 of 431
Better than 87% of the companies in the industry
Number of employees58No. 36 of 431
Better than 92% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 2,150of 4,412
Better than 51%
No. 1,036of 4,466
Better than 77%
Same industry and 50–199 employees27 companies in the comparison
No. 18of 26
Better than 32%
No. 13of 27
Better than 54%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 1,693of 24,791
Better than 93%
No. 1,992of 24,909
Better than 92%
All companies of type A/S18,025 companies in the comparison
No. 3,379of 17,786
Better than 81%
No. 3,158of 18,024
Better than 82%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Sanos A/SDKK 42.4m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Sanos A/SDKK 19.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Sanos A/SDKK 60.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Sanos A/S58
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Sanos Holding A/S100%
Sanos A/S

Management

5 active registrations

Executive management

Executive management at Sanos A/S
NameRoleAppointed
Mette Haugaard SkaksenDirector31/01/2024
Mark Høgh GandrupDirector01/01/2026

Board of directors

Board of directors at Sanos A/S
NameRoleAppointed
Jeppe Ragnar AndersenBoard member10/12/2020
Pierre KhaitrineChair of the board29/07/2026
José Ignacio PfeiferBoard member29/07/2026
Founders
Immunodiagnostic Systems Nordic A/S
Former management (24)
Former management at Sanos A/S
NameRoleAppointedResigned
Claus Henrik ChristiansenBoard member29/12/200309/07/2010
Jesper Bay EsbensenBoard member29/12/200310/05/2005
Dennis Bang HenriksenCEO29/12/200309/07/2010
Hans Robin PhilipChair of the board19/01/200424/06/2004
Viktor DrvotaBoard member19/01/200409/07/2010
Per Håkan Albin ÅströmChair of the board24/06/200419/02/2010
Charles Herve GirsaultBoard member10/05/200525/02/2010
Henrik LawaetzChair of the board03/03/201009/07/2010
Claus Høeg MadsenLiquidator09/07/201029/06/2015
Thomas NielsenLiquidator29/06/201516/11/2017
Claus Henrik ChristiansenChair of the board16/11/201710/12/2020
Thomas NielsenBoard member16/11/201710/12/2020
Morten Asser KarsdalBoard member16/11/201711/01/2018
Jeppe Ragnar AndersenCEO16/11/201701/07/2020
Bente Juel ChristiansenBoard member11/01/201810/12/2020
Henrik Bernt SandersBoard member01/07/202010/12/2020
Anne Sofie Bording AstrupDirector01/07/202012/11/2020
Jeppe Ragnar AndersenDirector12/11/202012/12/2021
Celine InfeldBoard member10/12/202031/01/2024
Karl Sebastian IngerChair of the board10/12/202029/07/2026
Henning Heiberg AndersenDirector13/12/202131/01/2024
Jeppe Ragnar AndersenCEO13/12/202131/01/2024
Jakob Brix ChristensenDirector31/01/202431/12/2025
Pierre KhaitrineBoard member31/01/202428/07/2026

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem og en direktør i forening, af to direktører i forening eller af den samlede bestyrelse i forening.

Address and production units

3 active production units

Herlev Hovedgade 82
2730 Herlev

Herlev Municipality · Postcode 2730

Production units
Production unitAddressEmployeesP number
Sanos A/SHerlev Hovedgade 82, 2730 Herlev571010283821
Sanos A/S VejleBoulevarden 19G, 7100 Vejle11025506304
Sanos A/S GandrupBorgergade 39, 9362 Gandrup–1025506312

Purpose

Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

79 registered events
20266 changesmanagement 5 · accounts 1
  • José Ignacio Pfeifer appointed board member
  • Pierre Khaitrine appointed chair of the board
  • Karl Sebastian Inger stepped down as chair of the board
  • Pierre Khaitrine stepped down as board member
  • Annual report for 2025 published
  • Mark Høgh Gandrup appointed director
20253 changesmanagement 1 · accounts 1 · industry 1
  • Jakob Brix Christensen stepped down as director
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20247 changesaccounts 1 · management 6
  • Annual report for 2023 published
  • Jakob Brix Christensen appointed director
  • Mette Haugaard Skaksen appointed director
  • Pierre Khaitrine appointed board member
  • Jeppe Ragnar Andersen stepped down as ceo
  • Henning Heiberg Andersen stepped down as director
  • Celine Infeld stepped down as board member
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20214 changesmanagement 3 · accounts 1
  • Jeppe Ragnar Andersen appointed ceo
  • Henning Heiberg Andersen appointed director
  • Jeppe Ragnar Andersen stepped down as director
  • Annual report for 2020 published
202014 changesmanagement 12 · ownership 2
  • Celine Infeld appointed board member
  • Jeppe Ragnar Andersen appointed board member
  • Karl Sebastian Inger appointed chair of the board
  • Henrik Bernt Sanders stepped down as board member
  • Bente Juel Christiansen stepped down as board member
  • Thomas Nielsen stepped down as board member
  • Claus Henrik Christiansen stepped down as chair of the board
  • Jeppe Ragnar Andersen appointed director
  • Anne Sofie Bording Astrup stepped down as director
  • Henrik Bernt Sanders appointed board member
  • Anne Sofie Bording Astrup appointed director
  • Jeppe Ragnar Andersen stepped down as ceo
  • Sanos Holding A/S registered as owner (100%)
  • NORDIC BIOSCIENCE HOLDING A/S is no longer registered as owner
20186 changesaddress 1 · ownership 2 · name 1 · management 2
  • Moved to Herlev Hovedgade 82, 2730 Herlev
  • NORDIC BIOSCIENCE HOLDING A/S registered as owner (100%)
  • NBCD A/S is no longer registered as owner
  • Name changed from SANOS BIOSCIENCE A/S to Sanos A/S
  • Bente Juel Christiansen appointed board member
  • Morten Asser Karsdal stepped down as board member
20176 changesstatus 1 · capital 1 · management 4
  • Status changed to active
  • Share capital changed from 2,200,000 DKK to 500,000 DKK
  • Jeppe Ragnar Andersen appointed ceo
  • Morten Asser Karsdal appointed board member
  • Thomas Nielsen appointed board member
  • Claus Henrik Christiansen appointed chair of the board
20152 changesaddress 1 · ownership 1
  • Moved to Herlev Hovedgade 207, 2730 Herlev
  • NBCD A/S registered as owner (90%)
20108 changesstatus 1 · management 7
  • Status changed to in voluntary liquidation
  • Henrik Lawaetz stepped down as chair of the board
  • Viktor Drvota stepped down as board member
  • Claus Henrik Christiansen stepped down as board member
  • Dennis Bang Henriksen stepped down as ceo
  • Henrik Lawaetz appointed chair of the board
  • Charles Herve Girsault stepped down as board member
  • Per Håkan Albin Åström stepped down as chair of the board
20081 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20073 changesaddress 1 · capital 1 · industry 1
  • Moved to Lersø Parkallé 42-44, 5. th, 2100 København Ø
  • Share capital changed from 2,000,000 DKK to 2,200,000 DKK
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
20061 changecapital 1
  • Share capital changed from 1,800,000 DKK to 2,000,000 DKK
20056 changescapital 3 · address 1 · management 2
  • Share capital changed from 1,600,000 DKK to 1,800,000 DKK
  • Moved to Glerupvej 2, 2610 Rødovre
  • Share capital changed from 1,260,000 DKK to 1,600,000 DKK
  • Share capital changed from 1,200,000 DKK to 1,260,000 DKK
  • Charles Herve Girsault appointed board member
  • Jesper Bay Esbensen stepped down as board member
20046 changesmanagement 4 · capital 1 · industry 1
  • Per Håkan Albin Åström appointed chair of the board
  • Hans Robin Philip stepped down as chair of the board
  • Share capital changed from 800,000 DKK to 1,200,000 DKK
  • Viktor Drvota appointed board member
  • Hans Robin Philip appointed chair of the board
  • Industry changed to Fremstilling af andre kemiske produkter i øvrigt (246600)
20034 changesfounded 1 · management 3
  • Registered as SANOS BIOSCIENCE A/S
  • Claus Henrik Christiansen appointed board member
  • Dennis Bang Henriksen appointed ceo
  • Jesper Bay Esbensen appointed board member

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction